Bottom Article Ad

Wednesday, July 21, 2021

Global Hereditary Angioedema Therapeutic Market to be Driven by Increasing Awareness Among General Population in the Forecast Period of 2021-2026

The new report by Expert Market Research titled, ‘Global Hereditary Angioedema Therapeutic Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2021-2026’, gives in-depth analysis of the Global Hereditary Angioedema Therapeutic Market, assessing the market based on its segments like categorised, treatment types, route of administration, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.

Note 1: For a snapshot of the primary and secondary data of the market (2016-2026), along with business strategies and detailed market segmentation, please click on request sample report. The sample report shall be delivered to you within 24 hours.

Request a free sample copy in PDF or view the report summary@

The key highlights of the report include:

Market Overview (2016-2026):

  • Historical Market Size (2020): USD 2.7 Billion
  • Forecast CAGR (2021-2026): 7%
  • Forecast Market Size (2026): USD 4.5 Billion

The growing awareness-raising actions among the general community are driving the hereditary angioedema treatment market. The main cause of misdiagnosis is a lack of understanding of hereditary angioedema therapeutics, which leads to patients receiving inadequate therapy. Appendicitis, gastrointestinal issues, and other non-allergic angioedema illnesses are misdiagnosed in some people with hereditary angioedema. A vast pool of individuals with high medical demands is created by a small number of patients misdiagnosed for the condition. In the coming years, this is projected to be a major market driver for hereditary angioedema therapeutics.

Industry Definition and Major Segments

Hereditary angioedema is a rather uncommon hereditary condition. Repeated episodes of significant swelling of the limbs, digestive system, face, and airway are common symptoms of the condition. There are three different types of this disease: Type I HAE, Type II HAE, and Type III HAE are the three types of HAE.

The industry can be broadly categorised based on drug class into:

  • C1-Esterase Inhibitor
  • Bradykinin B2 Receptor Antagonist
  • Kallikrein Inhibitor
  • Others

The industry can be divided based on treatment types as:

  • Prophylaxis Treatment
  • On-Demand Treatment

The industry can be classified based on the route of administration:

Based on region, the market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market Trends

The global increase in incidence of hereditary angioedema (HAE) is a major market driver. According to the National Organization for Rare Disorders (NORD), the illness affects 1-9 persons per 100,000 people. Because of under-reporting and misdiagnosis, the true number of people with the disease is far greater. Misdiagnosis is common due to a lack of knowledge regarding HAE, which results in patients receiving poor therapy. Most people with hereditary angioedema are misdiagnosed as having appendicitis, gastrointestinal problems, or other non-allergic angioedema. A large number of people have been misdiagnosed for the ailment, resulting in a large patient pool with significant medical demands. This will very certainly be a major driving force in the market. Another aspect contributing to the market’s growth is the rise of activities aimed at raising public awareness. The initiative’s goal is to help patients get a faster diagnosis and receive the best treatment and care possible. To meet the significant unmet medical need, pharmaceutical drug companies are increasingly focusing on developing innovative therapies for hereditary angioedema. Because of new product releases by major companies, a superior reimbursement scenario, and well-developed healthcare infrastructure, North America led the market in terms of revenue. The FDA, for example, gave regulatory approval for Cinryze for expanded use in paediatric patients aged 6 and up. During the projected period, Asia Pacific is predicted to grow at the fastest rate. The market in the region is likely to be driven by rising patient awareness and the introduction of newer medicines for the treatment of hereditary angioedema.

Explore the full report with the table of contents@

Key Market Players

The major players in the market are Shire Plc (Takeda), BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Ionis Pharmaceuticals, Inc., Pharming Group N.V., CSL Limited, Attune Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Note 2: As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Read More Reports:-

Global Biodegradable Plastic Market:

Global Cloud Kitchen Market:

Global Blackstrap Molasses Market:

North America Tomato Processing Market:

Global Sodium Monochloro Acetate Market:

Global Epigenetics Market:

Global Digital Therapeutics Market:

Global Coco Coir Market:

Global Metal Finishing Market:

Global Probiotic Supplements Market:

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

We also provide state-of-the-art procurement intelligence through our platform, Procurement Resource is a leading platform for digital procurement solutions, offering daily price tracking, market intelligence, supply chain intelligence, procurement analytics, and category insights through our thoroughly researched and infallible market reports, production cost reports, price analysis, and benchmarking.

Informes de Expertos (, the Spanish variant of Expert Market Research, is a platform that offers market research and consultancy services to a broad clientele base across Spanish speaking countries. With our primary focus on the Latin America and Spain markets, our research experts provide relevant and actionable insights into the markets and track major trends, economic developments, and global trade data.

Determined to bring client satisfaction, we make sure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and customized research reports cover a wide spectrum of industries ranging from pharmaceuticals and food and beverage to packaging, logistics, and transportation.

Media Contact

Company Name: EMR Inc.
Contact Person: Sofia Williams, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Read about global centrifugal blower market:

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.


Post a Comment